In prostate cancer, high expression of the lncRNA SChLAP1 correlates with aggressive tumour phenotypes and metastasis, and experimental evidence suggests that SChLAP1 antagonizes the tumour suppressive functions of the SWI/SNF complex (Prensner et al., 2013) (Fig. 3B). The gene discussed is SCHLAP1; the disease is prostate cancer.